132 related articles for article (PubMed ID: 1654136)
1. Neuroendocrine effects of diazepam in panic and generalized anxiety disorders.
Roy-Byrne PP; Cowley DS; Hommer D; Ritchie J; Greenblatt D; Nemeroff C
Biol Psychiatry; 1991 Jul; 30(1):73-80. PubMed ID: 1654136
[TBL] [Abstract][Full Text] [Related]
2. Effect of acute and chronic benzodiazepines on plasma GABA in anxious patients and controls.
Roy-Byrne PP; Cowley DS; Hommer D; Greenblatt DJ; Kramer GL; Petty F
Psychopharmacology (Berl); 1992; 109(1-2):153-6. PubMed ID: 1365649
[TBL] [Abstract][Full Text] [Related]
3. Diazepam and propranolol in panic disorder and agoraphobia.
Noyes R; Anderson DJ; Clancy J; Crowe RR; Slymen DJ; Ghoneim MM; Hinrichs JV
Arch Gen Psychiatry; 1984 Mar; 41(3):287-92. PubMed ID: 6367691
[TBL] [Abstract][Full Text] [Related]
4. The corticotropin-releasing hormone stimulation test in patients with panic disorder.
Roy-Byrne PP; Uhde TW; Post RM; Gallucci W; Chrousos GP; Gold PW
Am J Psychiatry; 1986 Jul; 143(7):896-9. PubMed ID: 3013032
[TBL] [Abstract][Full Text] [Related]
5. Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.
Kahn RS; Wetzler S; Asnis GM; Kling MA; Suckow RF; van Praag HM
Psychiatry Res; 1991 Apr; 37(1):25-34. PubMed ID: 1650487
[TBL] [Abstract][Full Text] [Related]
6. Psychoimmunoendocrine aspects of panic disorder.
Brambilla F; Bellodi L; Perna G; Battaglia M; Sciuto G; Diaferia G; Petraglia F; Panerai A; Sacerdote P
Neuropsychobiology; 1992; 26(1-2):12-22. PubMed ID: 1335559
[TBL] [Abstract][Full Text] [Related]
7. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
McCann UD; Slate SO; Geraci M; Uhde TW
Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
[TBL] [Abstract][Full Text] [Related]
8. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
Dunner DL; Ishiki D; Avery DH; Wilson LG; Hyde TS
J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model.
Abelson JL; Weg JG; Nesse RM; Curtis GC
Psychoneuroendocrinology; 1996 May; 21(4):375-90. PubMed ID: 8844876
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine effects of ovine corticotropin-releasing hormone in panic disorder patients.
Rapaport MH; Risch SC; Golshan S; Gillin JC
Biol Psychiatry; 1989 Aug; 26(4):344-8. PubMed ID: 2548630
[TBL] [Abstract][Full Text] [Related]
11. Lactate-induced anxiety after imipramine and diazepam treatment.
Pohl R; Balon R; Berchou R; Lycaki H
Anxiety; 1994; 1(2):54-63. PubMed ID: 9160549
[TBL] [Abstract][Full Text] [Related]
12. Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder.
Klein E; Zinder O; Colin V; Zilberman I; Levy N; Greenberg A; Lenox RH
Acta Psychiatr Scand; 1995 Dec; 92(6):399-408. PubMed ID: 8837965
[TBL] [Abstract][Full Text] [Related]
13. Carbon dioxide-induced anxiety. Behavioral, physiologic, and biochemical effects of carbon dioxide in patients with panic disorders and healthy subjects.
Woods SW; Charney DS; Goodman WK; Heninger GR
Arch Gen Psychiatry; 1988 Jan; 45(1):43-52. PubMed ID: 3122696
[TBL] [Abstract][Full Text] [Related]
14. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
Ströhle A; Holsboer F; Rupprecht R
Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
[TBL] [Abstract][Full Text] [Related]
15. Cortisol and sodium lactate-induced panic.
Hollander E; Liebowitz MR; Gorman JM; Cohen B; Fyer A; Klein DF
Arch Gen Psychiatry; 1989 Feb; 46(2):135-40. PubMed ID: 2913972
[TBL] [Abstract][Full Text] [Related]
16. Behavioral, neuroendocrine, and biochemical effects of 5-hydroxytryptophan administration in panic disorder.
den Boer JA; Westenberg HG
Psychiatry Res; 1990 Mar; 31(3):267-78. PubMed ID: 2139731
[TBL] [Abstract][Full Text] [Related]
17. Adrenergic function in patients with panic anxiety.
Nesse RM; Cameron OG; Curtis GC; McCann DS; Huber-Smith MJ
Arch Gen Psychiatry; 1984 Aug; 41(8):771-6. PubMed ID: 6331337
[TBL] [Abstract][Full Text] [Related]
18. Effect of benzodiazepines on plasma levels of homovanillic acid in anxious patients and control subjects.
Wingerson DK; Cowley DS; Kramer GL; Petty F; Roy-Byrne PP
Psychiatry Res; 1996 Nov; 65(1):53-9. PubMed ID: 8953661
[TBL] [Abstract][Full Text] [Related]
19. Blunted growth hormone response to clonidine in patients with generalized anxiety disorder.
Abelson JL; Glitz D; Cameron OG; Lee MA; Bronzo M; Curtis GC
Arch Gen Psychiatry; 1991 Feb; 48(2):157-62. PubMed ID: 1989571
[TBL] [Abstract][Full Text] [Related]
20. Megestrol attenuates the hormonal response to CCK-4-induced panic attacks.
Raedler TJ; Jahn H; Goedeken B; Gescher DM; Kellner M; Wiedemann K
Depress Anxiety; 2006; 23(3):139-44. PubMed ID: 16470820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
